Platelet activation patterns in platelet size sub-populations: Differential responses to aspirin in vitro

Journal of Thrombosis and Thrombolysis

Volumn 30, Issue 3, 2010, Pages 251-262

  Mangalpally, Kiran Kumar R ^a   Siqueiros Garcia, Alan ^a   Vaduganathan, Muthiah ^a   Dong, Jing Fei ^b   Kleiman, Neal S ^a   Guthikonda, Sasidhar ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aspirin; Fibrinogen; Platelets; Thromboxane; Von Willebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; FIBRINOGEN; MEMBRANE PROTEIN; PADGEM PROTEIN; THIAZOLE ORANGE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOXANE B2; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CELL SELECTION; CELL SIZE; CELL STIMULATION; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE STRUCTURE;

ACID PHOSPHATASE; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; CELL SIZE; CELLS, CULTURED; FIBRINOGEN; HUMANS; ISOENZYMES; P-SELECTIN; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOXANE B2; VON WILLEBRAND FACTOR;

EID: 77957946232     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0489-x     Document Type: Article

References (41)

1. S Karpatkin 1969 Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets J Clin Invest 48 6 1073 1082 1:CAS:528:DyaF1MXksFyltLs%3D 10.1172/JCI106063 5771188
2. S Karpatkin 1969 Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets J Clin Invest 48 6 1083 1087 1:CAS:528:DyaF1MXksFyltLg%3D 10.1172/JCI106064 5771189
3. AJ Bancroft, et al. 2000 Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer Platelets 11 7 379 387 1:CAS:528:DC%2BD3cXoslyrtbw%3D 10.1080/09537100020008311 11132104
4. L Pizzulli, et al. 1998 Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain Eur Heart J 19 1 80 84 1:STN:280:DyaK1c7mtl2juw%3D%3D 10.1053/euhj.1997.0747 9503179 (Pubitemid 28112303)
5. G Endler, et al. 2002 Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease Br J Haematol 117 2 399 404 10.1046/j.1365-2141.2002.03441.x 11972524 (Pubitemid 34451156)
6. MM Khandekar, et al. 2006 Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario J Clin Pathol 59 2 146 149 1:STN:280:DC%2BD28%2FlvVOltQ%3D%3D 10.1136/jcp.2004. 025387 16443728 (Pubitemid 43235577)
7. A Yang L Pizzulli B Luderitz 2006 Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris Thromb Res 117 4 371 377 1:CAS:528:DC%2BD28XhtlGjsr0%3D 10.1016/j.thromres.2005.04.004 15935453 (Pubitemid 43197487)
8. S Greisenegger, et al. 2004 Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 35 7 1688 1691 1:STN:280:DC%2BD2czhs1Oquw%3D%3D 10.1161/01.STR. 0000130512.81212.a2 15143290 (Pubitemid 38823648)
9. P Bath, et al. 2004 Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease Stroke 35 3 622 626 10.1161/01.STR.0000116105.26237.EC 14976328 (Pubitemid 38280830)
10. A Choudhury, et al. 2007 Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm J Am Coll Cardiol 49 19 1957 1964 1:CAS:528:DC%2BD2sXlt1amtL0%3D 10.1016/j.jacc.2007.02.038 17498581 (Pubitemid 46695928)
11. N Papanas, et al. 2004 Mean platelet volume in patients with type 2 diabetes mellitus Platelets 15 8 475 478 1:CAS:528:DC%2BD2cXhtVarsrvO 10.1080/0953710042000267707 15763888 (Pubitemid 39656855)
12. Y Tavil, et al. 2007 Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease Thromb Res 120 2 245 250 1:CAS:528:DC%2BD2sXlsFKgtr8%3D 10.1016/j.thromres.2006.10.005 17145074 (Pubitemid 46759554)
13. Collaborative Overview of Randomised Trials of Antiplatelet Therapy-I (1994) Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists' collaboration. BMJ 308(6921):81-106
14. KH Grotemeyer HW Scharafinski IW Husstedt 1993 Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients Thromb Res 71 5 397 403 1:STN:280:DyaK2c%2FlsVentQ%3D%3D 10.1016/0049-3848(93)90164-J 8236166 (Pubitemid 23244328)
15. PA Gum, et al. 2003 A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 6 961 965 1:CAS:528:DC%2BD3sXislejsLo%3D 10.1016/S0735-1097(02)03014-0 12651041 (Pubitemid 36315537)
16. JW Eikelboom, et al. 2002 Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 14 1650 1655 1:CAS:528:DC%2BD38Xjs12ns70%3D 10.1161/01.CIR.0000013777.21160.07 11940542 (Pubitemid 34298607)
17. G Krasopoulos, et al. 2008 Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 7637 195 198 10.1136/bmj.39430.529549.BE 18202034 (Pubitemid 351212675)
18. S Guthikonda, et al. 2007 Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin J Thromb Haemost 5 3 490 496 1:CAS:528:DC%2BD2sXktFCju7s%3D 10.1111/j.1538-7836.2007.02387.x 17319904 (Pubitemid 46680680)
19. S Guthikonda, et al. 2008 Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease J Am Coll Cardiol 52 9 743 749 1:CAS:528:DC%2BD1cXhtVarsLbM 10.1016/j.jacc.2008.05.031 18718422
20. CB Thompson, et al. 1984 Platelet size and age determine platelet function independently Blood 63 6 1372 1375 1:STN:280:DyaL2c3gsVSlsw%3D%3D 6722354
21. M Morigi, et al. 2001 Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress Blood 98 6 1828 1835 1:CAS:528:DC%2BD3MXntFWgtrs%3D 10.1182/blood.V98.6. 1828 11535517
22. JE Wall, et al. 1995 A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents Br J Haematol 89 2 380 385 1:STN:280:DyaK2M7nvVehsg%3D%3D 10.1111/j.1365-2141.1995.tb03315.x 7873389
23. B Balint, et al. 2002 Quantitative, functional, morphological and ultrastructural recovery of platelets as predictor for cryopreservation Haematologia (Budap) 32 4 363 375
24. D Bakovic, et al. 2009 Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients Clin Exp Pharmacol Physiol 36 4 441 446 1:CAS:528:DC%2BD1MXkslCksLk%3D 10.1111/j.1440-1681.2008.05090.x 19702597
25. KG Chamberlain, et al. 1989 The relationship of human platelet density to platelet age: platelet population labeling by monoamine oxidase inhibition Blood 73 5 1218 1225 1:STN:280:DyaL1M7psVelug%3D%3D 2522800
26. P Jaremo, et al. 2009 Elevated platelet density and enhanced platelet reactivity in stable angina pectoris complicated by diabetes mellitus type II Thromb Res 124 3 373 374 1:STN:280:DC%2BD1MvnvFWgtA%3D%3D 10.1016/j.thromres. 2008.12.042 19230957
27. TO Apelseth T Hervig 2007 In vitro evaluation of platelet concentrates during storage: Platelet counts and markers of platelet destruction Transfus Apher Sci 37 3 261 268 10.1016/j.transci.2007.02.006 18036986 (Pubitemid 350181791)
28. CJ Boos B Balakrishnan GY Lip 2008 The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood J Thromb Thrombolysis 25 2 135 140 10.1007/s11239-007-0034-8 17574521 (Pubitemid 351583661)
29. M Milovanovic, et al. 2003 Identification of low-density platelet populations with increased reactivity and elevated alpha-granule content Thromb Res 111 1-2 75 80 1:CAS:528:DC%2BD3sXptl2ru7Y%3D 10.1016/j.thromres.2003.08.019 14644083 (Pubitemid 37485929)
30. P Jaremo, et al. 2001 Inverse relationship between platelet density and reactivity alterations at coronary angiography Haemostasis 31 1 55 60 1:STN:280:DC%2BD3MzksFehtw%3D%3D 11408750
31. P Jaremo, et al. 2000 The use of platelet density and volume measurements to estimate the severity of pre-eclampsia Eur J Clin Invest 30 12 1113 1118 1:STN:280:DC%2BD3M7kvVWhug%3D%3D 10.1046/j.1365-2362.2000.00753.x 11122327 (Pubitemid 32064061)
32. P Jaremo H Sandberg-Gertzen 1996 Platelet density and size in inflammatory bowel disease Thromb Haemost 75 4 560 561 1:STN:280: DyaK28zgt1Oltw%3D%3D 8743178
33. P Noris, et al. 2009 Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia J Thromb Haemost 7 12 2131 2136 1:CAS:528:DC%2BC3cXhtVWjsLw%3D 10.1111/j.1538-7836.2009.03614.x 19740094
34. K Kario T Matsuo K Nakao 1992 Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis Clin Lab Haematol 14 4 281 287 1:STN:280:DyaK3s7itFKqsw%3D%3D 10.1111/j.1365-2257. 1992.tb00103.x 1478007
35. E Coban, et al. 2005 The mean platelet volume in patients with obesity Int J Clin Pract 59 8 981 982 1:STN:280:DC%2BD2Mzns1Giug%3D%3D 10.1111/j.1742-1241.2005.00500.x 16033624
36. S Nadar AD Blann GY Lip 2004 Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy Ann Med 36 7 552 557 1:CAS:528:DC%2BD2cXos1GhtL8%3D 10.1080/07853890410017386 15513305 (Pubitemid 39490964)
37. R Pathansali N Smith P Bath 2001 Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia Platelets 12 5 292 297 1:CAS:528:DC%2BD3MXlslKmu7o%3D 10.1080/09537100120058810 11487381 (Pubitemid 32730516)
38. SK Braekkan, et al. 2009 Mean platelet volume is a risk factor for venous thromboembolism - the Tromso study J Thromb Haemost 8 1 157 162 10.1111/j.1538-7836.2009.03498.x 19496920
39. MA Packham, et al. 1989 Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents Thromb Haemost 62 3 968 976 1:CAS:528:DyaK3cXlt12hug%3D%3D 2512683
40. EI Lev, et al. 2007 Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects Am J Cardiol 99 1 124 128 1:CAS:528: DC%2BD2sXhsFGqsg%3D%3D 10.1016/j.amjcard.2006.07.074 17196475 (Pubitemid 44969352)
41. SC Smith Jr, et al. 2006 AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 19 2363 2372 10.1161/CIRCULATIONAHA.106.174516 16702489 (Pubitemid 43947981)